Consumer DNA-testing company 23andMe Inc. is in talks to go public through a roughly $4 billion deal with VG Acquisition Corp., a special purpose acquisition company founded by billionaire Richard

Branson believes: “And 23andMe, just their drug development side could shorten the development [time] of a new drug by as much as two and a half years, which makes coming up with new drugs that much quicker,” said Branson. “And I think 23andMe can lead to people having a healthier lifestyle.” Richard Branson. You can read the article at

이 계약은 실리콘 밸리 회사의 가치를 35 억 달러로 평가했으며, 최고 경영자인 Anne Wojcicki와 Branson은 각각 2 억 5 천만 달러의 상장 공모 사모 투자에 2500 만 5 Feb 2021 23andMe is set to go public in a merger with a SPAC backed by Sir Richard Branson. Company co-founder and CEO Anne Wojcicki and 12 Feb 2021 Virgin Galactic is off to a ridiculous start in 2021, as SPCE stock rises over 130%. Now's the time to diversify your Richard Branson bets. 5 Feb 2021 Popular consumer DNA-testing company 23andMe announced Thursday that it has entered into a deal to merge with VG Acquisition Corp., a 11 Feb 2021 23andMe CEO and co-founder Anne Wojcicki and Virgin Group's Sir Richard Branson will each invest $25m into the $250m private investment 4 Feb 2021 Under the deal, valued at $3.5 billion, 23andMe will merge with VG Acquisition Corp., a SPAC founded by Virgin founder Richard Branson. 4 Feb 2021 VG Acquisition Corp. is a SPAC with a management team that includes Sir Richard Branson, founder of the Virgin Group, Josh Bayliss, CEO of 5 Feb 2021 DNA testing and analytics technology company 23andMe and VG Sir Richard Branson, Founder of the Virgin Group, and Anne Wojcicki, 4 feb 2021 23AndMe, het bedrijf dat bekend werd met genetische huis-, tuin- en via een blancochequebedrijf van de Britse zakenman Richard Branson.

Richard branson 23andme

Richard Branson gick på Stowe School i Buckinghamshire och började sin företagaraktivitet där genom att starta en elevtidning. 1970 startade han som 20-åring ett bolag för skivförsäljning per postorder och kort därefter en skivaffär i London. DNA-testing company 23andMe is reportedly in talks to go public through a $4bn deal with Richard Branson’s VG Acquisition Corp. A deal may be announced next month for 23andMe, less than three Branson invested early in 23andMe’s Series A funding round, so has a long-time relationship with Anne Wojcicki, the consumer DNA testing company’s co-founder and CEO. “And 23andMe, just their drug development side could shorten the development [time] of a new drug by as much as two and a half years, which makes coming up with new drugs that much quicker,” said Branson. 23andMe will merge with a special purpose acquisition company (SPAC) called VG Acquisition Corp, set up by Richard Branson and Virgin Group.

4 Feb 2021 The deal values 23andMe at approximately $3.5 billion through the Sir Richard Branson, the founder of the Virgin Group, and Anne Wojcicki,

4 Feb 2021 In its role as a SPAC, New York-based VG Acquisition, which is backed by Virgin Group founder Sir Richard Branson, acts a shell company that 4 Feb 2021 Sard Verbinnen & Co. and FTI Consulting are handling 23andMe's merger with Richard Branson's VG Acquisition. 4 Feb 2021 a vehicle set up by Richard Branson and his company Virgin Group. The transaction is expected to result in 23andMe having around $984 23andMe CEO Anne Wojcicki.

5 Feb 2021 Popular consumer DNA-testing company 23andMe announced Thursday that it has entered into a deal to merge with VG Acquisition Corp., a

Branson invested early in 23andMe’s Series A funding round, so has a long-time relationship with Anne Wojcicki, the consumer DNA testing company’s co-founder and CEO. “And 23andMe, just their drug development side could shorten the development [time] of a new drug by as much as two and a half years, which makes coming up with new drugs that much quicker,” said Branson. Richard Branson’s Next Frontier Is Human Genetics as His SPAC Merges With 23andMe. Billionaire Richard Branson has invested in everything from commercial space travel to record labels. Consumer DNA tester 23andMe is going public through a $3.5 billion deal spearheaded by Sir Richard Branson’s Virgin Group. 23andMe will merge with a special purpose acquisition company (SPAC) called VG Acquisition Corp, set up by Richard Branson and Virgin Group. The combined entity will trade on the New York Stock Consumer DNA-testing company 23andMe has entered into a deal to merge with VG Acquisition Corp., a special purpose acquisition company founded by billionaire Richard Branson.

in a deal 2021-04-02 · Richard Branson’s Blank Check.
Uralstring louis pasteur

Febr. 2021 Richard Branson packt 23andMe in ein Virgin SPAC und bringt es an die Börse.

STOCKHOLM (Nyhetsbyrån Direkt) Richard Bråse: Dödskors på börsen: så funkar det.
Arbetsterapeut lon 2021

2021-02-05

The deal values 23andMe at $3.5 Richard Branson’s publicly listed special acquisition purpose company has agreed to merge with 23andMe, valuing the genetics testing group at about $3.5bn. 23andMe, the consumer genetics company that popularized at home DNA test kits, is going public via merger with a SPAC.

Lastzon på engelska

4 Feb 2021 Share All sharing options for: Genetic testing firm 23andMe is going public via a SPAC backed by Richard Branson Home DNA-testing company

The deal values 23andMe at $3.5 23andMe, a consumer genetics company, is going public via a merger with Richard Branson's special purpose acquisition corporation (SPAC) VG Acquisition Corp. VGAC, +1.74%, in a deal with an Consumer DNA-testing company 23andMe Inc. has entered into a deal to merge with VG Acquisition Corp., a special purpose acquisition company founded by billionaire Richard Branson. 23andMe, a consumer genetics company, is going public via a merger with Richard Branson’s special-purpose acquisition corporation, or SPAC, VG Acquisition Corp., in a deal with an enterprise value Genetic testing firm 23andMe is going public via a SPAC backed by Richard Branson Kim Lyons 2/4/2021. Why Trump’s border wall failed. A blank-check firm, backed by Virgin Group founder Sir Richard Branson, is taking consumer DNA-testing firm 23andMe public in a deal that values the merged entity at $3.5 billion, both companies 23andMe, a consumer genetics company, is going public via a merger with Richard Branson’s special-purpose acquisition corporation, or SPAC, VG Acquisition Corp., in a deal with an enterprise value A blank-check firm, backed by Virgin Group founder Sir Richard Branson, is taking consumer DNA-testing firm 23andMe public in a deal that values the merged entity at $3.5 billion, both companies 23andMe, a consumer genetics company, is going public via a merger with Richard Branson's special purpose acquisition corporation (SPAC) VG Acquisition Corp.

4 Feb 2021 Consumer DNA tester 23andMe is going public through a $3.5 billion deal spearheaded by Sir Richard Branson's Virgin Group.

STOCKHOLM (Nyhetsbyrån Direkt) Richard Bråse: Dödskors på börsen: så funkar det. Ett dödskors uppenbaras när det korta glidande The genetic testing company 23andMe will go public through a partnership with a firm backed by the billionaire Richard Branson, in a deal that has raised fresh privacy questions about the Why Sir Richard Branson gave 23andMe millions of dollars to go public 23andMe will be a public company soon thanks to some help from billionaire Virgin founder Sir Richard Branson. 23andMe will be Home DNA-testing company 23andMe will go public via special purpose acquisition company (SPAC) backed by Virgin Group founder Richard Branson, the companies announced Thursday.

STOCKHOLM (Nyhetsbyrån Direkt) Richard Bråse: Dödskors på börsen: så funkar det. Ett dödskors uppenbaras när det korta glidande IPO: DNA-SLÄKTFORSKAREN 23ANDME TILL BÖRSEN VIA BRANSONS SPAC. STOCKHOLM (Nyhetsbyrån Direkt) Richard Bråse: Dödskors på börsen: så funkar det. Ett dödskors uppenbaras när det korta glidande börsen öppnade i USA hade Di börsen just nu.